Navigation Links
Ohio State study: Targeted ovarian cancer therapy not cost-effective
Date:3/7/2011

eatment with standard chemotherapy drugs carboplatin and paclitaxel along with bevacizumab.

"We put together a model looking at the variety of treatment arms on this clinical trial, each of which included 600 patients," said Cohn. "Given the fact that the addition of the drug was associated with 3.8 months of additional survival without cancer, we set out to determine whether or not that benefit of survival was justified by the expense of the drug."

The model showed that standard chemotherapy for patients in the clinical trial would cost $2.5 million, compared to $78.3 million for patients who were treated with standard chemotherapy and bevacizumab, plus additional maintenance treatments of bevacizumab for almost one year.

Bevacizumab has been used in the treatment of recurrent ovarian cancer, and the U.S. Food and Drug Administration has approved it for the treatment of colorectal, lung, breast, brain (glioblastoma) and renal cell cancers.

Typically each treatment with bevacizumab costs $5,000, with most of those costs directly attributable to the cost of the drug, Cohn said.

Effectiveness was defined as months of progression-free survival, and costs were calculated as total costs per strategy. Cost-effectiveness strategies were defined as the cost per year of progression-free survival. Incremental cost-effectiveness ratio was defined as the costs per progression-free life-year saved.

"Ultimately, we found that if you reduced the drug cost to 25 percent of the baseline, it does become cost effective to treat patients with bevacizumab," said Cohn. "Or, if the survival could be substantially increased above the 3.8 months of progression-free survival, that could lead to cost-effective treatment for patients with advanced ovarian cancer."

Ovarian cancer is the most lethal gynecologic cancer, with almost 14,000 women expected to die from the disease this year, according to the American Cancer Society.

"It is anticipated that in the
'/>"/>

Contact: Eileen Scahill
Eileen.Scahill@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. ACP applauds President Obamas call for state innovation on health insurance coverage
2. K-State chemists work brings more national recognition as promising early-career scientist
3. Rapid Rise in PSA Levels a Poor Predictor of Prostate Cancer: Study
4. Newer Drug May Help Prevent Fracture in Men With Prostate Cancer
5. PSA velocity screening for prostate cancer may lead to unnecessary biopsies
6. Change in PSA level does not predict prostate cancer
7. PSA Screening for Prostate Cancer Dips in Large U.S. Health Network
8. Wayne State University researchers publish results settling multiple sclerosis debate
9. Innovative International Healthcare Partnership established at Arizona State University
10. HJF signs distribution agreement for antibody to evaluate prostate cancer
11. 2010 AAAS Mentor Award goes to Dr. Joseph M. DeSimone of the University of North Carolina at Chapel Hill, and North Carolina State University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... Recently, BambooIndustry.com, one of the most popular suppliers ... bamboo deckings . Moreover, the company has launched ... now available at deeply discounted rates. , As ... overstate the significance of online business nowadays. Thus, BambooIndustry.com ... company’s workers are striving to deliver both value and ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 This ... for Partial Seizure, complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ... Seizure and special features on late-stage and discontinued ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest ... and HostMonster are the best VPS hosting suppliers ... is the method of partitioning a physical server ... the appearance and capabilities of running on someone’s ... pays close attention to VPS products and related ...
(Date:10/19/2014)... a professional company of women’s dresses and related accessories, ... dresses . All the company’s old and new client ... up to 66 percent off. , SweetDressy.com is ... Its dress specialists are striving to make more trendy ... world. All the company’s items are unique, graceful and ...
(Date:10/19/2014)... NY (PRWEB) October 20, 2014 Stephen T. ... has been nominated for the 10th consecutive year as one ... year Dr. Greenberg was also been nominated as the best ... was also nominated as best Day Spa and best Laser ... until December 14th and readers can vote for the contest ...
Breaking Medicine News(10 mins):Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2
... Tice, Pharm.D., chief,clinical officer of PharmMD, will be ... at its upcoming annual meeting, scheduled,for March 14-17 ... career accomplishments, Dr. Tice helped make medication,therapy management ... the process of,preventing drug error, overuse and abuse ...
... Care Center at ... Hospital, and Nyack Hospital, HACKENSACK, N.J., March 17 ... anticipated debut in The Kennedy Funding,Invitational for 2008, July 9-13. ... hospital breast care centers. Co-Directors,James Miller, Mitch Klein, and Kevin ...
... people live with diabetes across the world and 4.4 ... diabetes control can lead to devastating complications, like blood ... which cause 85% of all amputations. , The Faculty ... Club of Rotary International has just received a grant ...
... . , Scientists at the University of ... Haemoglobin transports oxygen in the red blood corpuscles. When ... type appears optically to be transporting little oxygen. Measurements ... picture to patients suffering from an inherited cardiac defect. ...
... Well Tolerated in 26-Week Study, WILMINGTON, Del., ... of the maintenance combination asthma therapy,SYMBICORT(R) (budesonide/formoterol fumarate ... 11 years old. The study examined the,safety of ... included efficacy,measures. For children previously treated with inhaled ...
... Parents Reported -, PHILADELPHIA, March 17 Data ... silent epidemic among our nation,s children.,U.S. children are suffering ... to the Pediatric Allergies in America survey, which is,the ... children,under the age of 18 who suffer from allergic ...
Cached Medicine News:Health News:PharmMD's Brad Tice Named APhA Fellow 2Health News:PharmMD's Brad Tice Named APhA Fellow 3Health News:Superstar John McEnroe to Highlight The Kennedy Funding Invitational Tennis Tournament, July 9-13, 2008 2Health News:Superstar John McEnroe to Highlight The Kennedy Funding Invitational Tennis Tournament, July 9-13, 2008 3Health News:Superstar John McEnroe to Highlight The Kennedy Funding Invitational Tennis Tournament, July 9-13, 2008 4Health News:Egyptian foot care center recieves International Diabetes Federation grant 2Health News:Bonn scientists discover new hemoglobin type 2Health News:Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma 2Health News:Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma 3Health News:Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma 4Health News:Landmark 'Pediatric Allergies in America' Survey Uncovered Negative Impact of Allergy Symptoms on Children 2Health News:Landmark 'Pediatric Allergies in America' Survey Uncovered Negative Impact of Allergy Symptoms on Children 3Health News:Landmark 'Pediatric Allergies in America' Survey Uncovered Negative Impact of Allergy Symptoms on Children 4Health News:Landmark 'Pediatric Allergies in America' Survey Uncovered Negative Impact of Allergy Symptoms on Children 5
(Date:10/20/2014)...   BioNano Genomics announced today achievement of a ... human data at 30X depth, sufficient for a genome map, ... was established and demonstrated for the IrysChip TM V2, ... and will be rolled out to BioNano,s collaborators and ... this advancement at the American Society for Human Genetics ...
(Date:10/20/2014)... N.J. , Oct. 20, 2014   ... Pharmaceutical Co., Ltd. ( Japan ), ... (FDA) granted Fast Track designation for TAS-102 (nonproprietary ... anticancer drug under investigation for the treatment of ... Company has initiated a rolling NDA submission to ...
(Date:10/20/2014)... 20, 2014 Pharmaceutic Labs announces the opening ... Albany, NY for admixing, compounding, drug ... and/or exceeds the FDA standards for safety and quality, ... 211. The 10,000 square foot outsourcing ... quality assurance and quality control. The company will produce ...
Breaking Medicine Technology:BioNano Genomics Announces One Human : One Chip : One Day 2BioNano Genomics Announces One Human : One Chip : One Day 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4
... Companies, Inc. (NYSE: PRX ) announced today that ... Strativa Pharmaceuticals and Executive Vice President of Par Pharmaceutical Companies ...  Patrick G. LePore, Par Pharmaceutical Companies, Chairman, CEO and President, ... Patrick G. LePore states, "In ...
... Mylan Inc. (Nasdaq: MYL ) today confirmed that ... sued by Shionogi Pharma Inc. and CIMA LABS INC. in ... (ANDA) with the U.S. Food and Drug Administration (FDA) for ... and 30 mg. This product is the generic version of ...
Cached Medicine Technology:John A. MacPhee Resigns From Strativa Pharmaceuticals 2Mylan Confirms First-to-File Patent Challenge Relating to Orapred ODT® 2
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
... Hormone (FSH) is intimately involved in the ... of the gonadal tissues, which synthesize and ... The levels of circulating FSH is controlled ... feedback relationship. The FSH Quantitative Test ...
... Our Class II Direct to High Res SSP kits ... a single tray. Locus specific typing on a single ... , Straight from genomic DNA to high resolution ... Allele level typing with a single tray , Unique ...
... Res SSP kits provide high resolution typing of the ... on a single tray reduces QC and testing costs ... to high resolution results, no need for initial low ... tray , Unique reaction pattern for most common alleles ...
Medicine Products: